Revitope Oncology Competitors and Similar CompaniesClear all
Infinity Pharmaceuticals's competitors and similar companies include GlycoMimetics and Exelixis.
 Infinity Pharmaceuticals Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions. |  GlycoMimetics GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers. | ||
Founding Date | Founding Date 2000 | Founding Date 2003 | Founding Date 1994 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Cambridge, US HQ | Locations Rockville, US HQ | Locations Alameda, US HQ |
Employees | Employees 25 | Employees 5025% increase | Employees 1,14712% decrease |
Valuation ($) | Valuation ($) 726.1 k | Valuation ($) 31.6 m | Valuation ($) 8.2 b |
Financial | |||
Revenue (est.) | Revenue (est.) $2.6m (FY, 2022) | Revenue (est.) $10.8m (FY, 2025) | Revenue (est.) $2.3b (FY, 2025) |
Net income | Net income ($44.4m) (FY, 2022) | Net income ($153.9m) (FY, 2025) | Net income $782.6m (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 106.6m | Total funding raised $ 101.8m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
GlycoMimetics
HQ
Rockville, US
Employees
50↑ 25% increase
GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.
View company
Exelixis
HQ
Alameda, US
Employees
1,147↓ 12% decrease
Exelixis is an oncology company that develops cancer treatments.
View company